Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Double-blinded Randomized Phase 2a Clinical Trial to Evaluate the Efficacy of SA001 for Dry Eye and Mouth Dryness in the Patients With Primary Sjögren's Syndrome

NCT05269810 is registered in ClinicalTrials.gov with Samjin Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT05269810
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05269810 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Double-blinded Randomized Phase 2a Clinical Trial to Evaluate the Efficacy of SA001 for Dry Eye and Mouth Dryness in the Patients With Primary Sjögren's Syndrome
Lead sponsor
Samjin Pharmaceutical Co., Ltd.
Phase
Phase 2
Overall status
Completed
Start date
May 29, 2020
Completion date
March 21, 2022
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary sjögren's syndrome (pss)